SeaStar Medical Holding Corporation (NASDAQ:ICU) Short Interest Update

SeaStar Medical Holding Corporation (NASDAQ:ICU) was the target of a significant drop in short interest during the month of February. As of February 27th, there was short interest totaling 233,272 shares, a drop of 18.5% from the February 12th total of 286,335 shares. Approximately 6.2% of the shares of the company are sold short. Based on an average daily volume of 43,336 shares, the short-interest ratio is currently 5.4 days. Based on an average daily volume of 43,336 shares, the short-interest ratio is currently 5.4 days. Approximately 6.2% of the shares of the company are sold short.

Hedge Funds Weigh In On SeaStar Medical

A number of hedge funds have recently made changes to their positions in the business. Trinity Financial Advisors LLC grew its holdings in SeaStar Medical by 233.3% during the 3rd quarter. Trinity Financial Advisors LLC now owns 50,000 shares of the company’s stock valued at $28,000 after buying an additional 35,000 shares in the last quarter. XTX Topco Ltd boosted its position in shares of SeaStar Medical by 395.4% during the second quarter. XTX Topco Ltd now owns 60,983 shares of the company’s stock worth $26,000 after acquiring an additional 48,674 shares during the last quarter. Jane Street Group LLC purchased a new position in SeaStar Medical during the fourth quarter valued at $30,000. Finally, Millennium Management LLC bought a new stake in SeaStar Medical in the 3rd quarter valued at $102,000. Institutional investors own 1.69% of the company’s stock.

Analyst Ratings Changes

ICU has been the topic of several recent research reports. Wall Street Zen upgraded shares of SeaStar Medical to a “hold” rating in a research report on Saturday, January 10th. Maxim Group set a $6.00 price objective on SeaStar Medical in a research note on Thursday, February 12th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of SeaStar Medical in a report on Thursday, January 22nd. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, SeaStar Medical presently has a consensus rating of “Sell” and a consensus price target of $6.00.

SeaStar Medical Stock Performance

Shares of NASDAQ ICU traded down $0.16 during midday trading on Monday, reaching $2.40. The stock had a trading volume of 112,946 shares, compared to its average volume of 51,843. SeaStar Medical has a 12-month low of $2.20 and a 12-month high of $25.70. The stock has a 50-day moving average of $2.50 and a 200-day moving average of $4.41.

About SeaStar Medical

SeaStar Medical, Inc (NASDAQ: ICU) is a medical device company focused on the development and commercialization of cerebral embolic protection systems for patients undergoing transcatheter aortic valve replacement (TAVR) procedures. The company’s mission is to reduce the risk of stroke and other neurologic events associated with structural heart interventions by capturing or deflecting embolic debris that can travel to the brain during catheter-based therapies.

The company’s flagship product, TriGUARD® 3, is a next-generation embolic deflection device designed to provide coverage of all three cerebral vessels during TAVR.